UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 1-Year-Old With Mycobacterium tuberculosis Endocarditis With Mass Spectrometry Analysis of Cardiac Vegetation Composition

Journal of the Pediatric Infectious Diseases Society, 2016-03, Vol.5 (1), p.85-88

2016

Volltextzugriff (PDF)

A 1-Year-Old With Mycobacterium tuberculosis Endocarditis With Mass Spectrometry Analysis of Cardiac Vegetation Composition: Table 1

Journal of the Pediatric Infectious Diseases Society, 2016-03, Vol.5 (1), p.85-88

2016

Volltextzugriff (PDF)

Abstract 1690: A tumor deconvolution DREAM Challenge: Inferring immune infiltration from bulk gene expression data

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1690-1690

2019

Volltextzugriff (PDF)

Abstract 2406: LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2406-2406

2017

Volltextzugriff (PDF)

Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4700-4700

2016

Volltextzugriff (PDF)

Abstract 4929: Leveraging multi-omics tumor boards for precision medicine in the OHSU SMMART Treatments Program

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4929-4929

2019

Volltextzugriff (PDF)

Abstract 5238: Acquired therapeutic resistance is mediated by deregulation of multiple pathways

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5238-5238

2013

Volltextzugriff (PDF)

Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5502-5502

2014

Volltextzugriff (PDF)

Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5551-5551

2018

Volltextzugriff (PDF)

Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.639-639

2011

Volltextzugriff (PDF)

Abstract 731: Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.731-731

2015

Volltextzugriff (PDF)

Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer

Cancer research (Chicago, Ill.), 2011-09, Vol.71 (18_Supplement), p.A58-A58

2011

Volltextzugriff (PDF)

Abstract B24: Genomic prediction of response to PARP inhibition in breast cancer

Molecular cancer research, 2017-04, Vol.15 (4_Supplement), p.B24-B24

2017

Volltextzugriff (PDF)

Abstract IA019: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit

Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3_Supplement_2), p.IA019-IA019

Heiser, Laura M.

2024

Volltextzugriff (PDF)

Abstract LB-240: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-240-LB-240

2018

Volltextzugriff (PDF)

Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB224-LB224

2024

Volltextzugriff (PDF)

Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-05-13

2015

Volltextzugriff (PDF)

Abstract P3-06-05: Evaluation of an in vitro derived signature of olaparib response (PARPi-7) as a predictive biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 TRIAL

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-06-05

2015

Volltextzugriff (PDF)

Abstract P5-05-01: Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-05-01

2015

Volltextzugriff (PDF)

Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-05-03

2015

Volltextzugriff (PDF)

Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.PD6-2-PD6-2

2015

Volltextzugriff (PDF)

Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes

Genome medicine, 2017-04, Vol.9 (1), p.40-19, Article 40

2017

Volltextzugriff (PDF)

An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells

Human molecular genetics, 2023-04, Vol.32 (9), p.1483-1496

2023

Volltextzugriff (PDF)

Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects

Nature communications, 2023-06, Vol.14 (1), p.3450-3450, Article 3450

2023

Volltextzugriff (PDF)

Analysis of molecular inversion probe performance for allele copy number determination

Genome biology, 2007-01, Vol.8 (11), p.R246-R246, Article R246

2007

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(107)
Bücher
(1)

Sprache

Englisch
(108)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(59)
Humans
(45)
Female
(28)
Animals
(21)
Breast Cancer
(21)
Cell Line, Tumor
(21)
Science & Technology - Other Topics
(18)
Cell Biology
(17)
Multidisciplinary Sciences
(17)
Oncology
(16)
Tumors
(14)
Biochemistry & Molecular Biology
(13)
Cancer
(13)
Mice
(12)
Science
(12)
Gene Expression
(11)
Humanities And Social Sciences
(11)
Multidisciplinary
(11)
Analysis
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A 1-Year-Old With Mycobacterium tuberculosis Endocarditis With Mass Spectrometry Analysis of Cardiac Vegetation Composition

A 1-Year-Old With Mycobacterium tuberculosis Endocarditis With Mass Spectrometry Analysis of Cardiac Vegetation Composition: Table 1

Abstract 1690: A tumor deconvolution DREAM Challenge: Inferring immune infiltration from bulk gene expression data

Abstract 2406: LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation

Abstract 4700: BET bromodomain inhibition is a promising treatment strategy for distinct subsets of lethal castration-resistant prostate cancer

Abstract 4929: Leveraging multi-omics tumor boards for precision medicine in the OHSU SMMART Treatments Program

Abstract 5238: Acquired therapeutic resistance is mediated by deregulation of multiple pathways

Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs

Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis

Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines

Abstract 731: Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer

Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer

Abstract B24: Genomic prediction of response to PARP inhibition in breast cancer

Abstract IA019: Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit

Abstract LB-240: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Abstract LB224: Neoplastic immune mimicry potentiates breast cancer progression

Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells

Abstract P3-06-05: Evaluation of an in vitro derived signature of olaparib response (PARPi-7) as a predictive biomarker of response to veliparib/carboplatin plus standard neoadjuvant therapy in high-risk breast cancer: Results from the I-SPY 2 TRIAL

Abstract P5-05-01: Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance

Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib

Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8

Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes

An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells

Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects

Analysis of molecular inversion probe performance for allele copy number determination

Suchergebnisse filtern